Company Filing History:
Years Active: 1986
Title: The Innovations of Erik K Frandsen
Introduction
Erik K Frandsen is a notable inventor based in Charlottenlund, Denmark. He has made significant contributions to the field of medicinal peptides, particularly in the development of novel compounds that have therapeutic applications. His work has the potential to impact the medical community positively.
Latest Patents
Frandsen holds a patent for the "Use of peptides as medicaments and certain novel peptides." This patent includes specific peptides containing the glucagon.sub.1-21 peptide chain, which are usable as a medicament or diagnostic tool. The peptide exhibits a spasmolytic effect and an inhibitory effect on gastric acid secretion, similar to glucagon, while maintaining a negligible metabolic effect. Some of the glucagon fragments he has developed are considered novel compounds.
Career Highlights
Erik K Frandsen is associated with Novo Industri A/S, a company known for its focus on innovative pharmaceutical solutions. His work at this organization has allowed him to explore the therapeutic potential of peptides extensively.
Collaborations
Frandsen has collaborated with notable colleagues, including Behrend Friedrich Lundt and Karin D Jorgensen. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.
Conclusion
Erik K Frandsen's contributions to the field of medicinal peptides highlight his innovative spirit and dedication to improving healthcare solutions. His patent and collaborations reflect a commitment to advancing medical science through research and development.